Safety and efficacy of a peri-operative protocol for patients with diabetes treated with continuous subcutaneous insulin infusion who are admitted for same-day surgery

Endocrine Practice

Volumn 21, Issue 11, 2015, Pages 1269-1276

  Sobel, Sandra I ^a   Augustine, Marilyn ^b   Donihi, Amy C ^c   Reider, Jodie ^a   Forte, Patrick ^a   Korytkowski, Mary ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; HEMOGLOBIN A1C; HYDROCORTISONE; INSULIN; METHYLPREDNISOLONE;

ADULT; AMBULATORY SURGERY; ARTICLE; DEVICE SAFETY; DIABETES MELLITUS; EFFICACY PARAMETERS; ELECTIVE SURGERY; ELECTRONIC MEDICAL RECORD; FEMALE; GENERAL ANESTHESIA; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN INFUSION; INSULIN PUMP; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATIENT SAFETY; PREOPERATIVE CARE; RETROSPECTIVE STUDY; SURGICAL TECHNIQUE; TERTIARY CARE CENTER; ADVERSE EFFECTS; PATIENT CARE; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATIONS; PROCEDURES; STANDARDS; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADULT; AMBULATORY SURGICAL PROCEDURES; CONTINUITY OF PATIENT CARE; DIABETES MELLITUS; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; TERTIARY CARE CENTERS; TREATMENT OUTCOME;

EID: 84979819542     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP15727.OR     Document Type: Article

References (26)

1. Grunberger G, Bailey TS, Cohen AJ, et al. Statement by the American Association of Clinical Endocrinologists Consensus Panel on insulin pump management. Endocr Pract. 2010;16:746-762.
2. Grunberger G, Abelseth JM, Bailey TS, et al. Consensus Statement by the American Association of Clinical Endocrinologists/American College of Endocrinology insulin pump management task force. Endocr Pract. 2014; 20:463-489.
3. Pitocco D, Rizzi A, Scavone G, et al. Fields of application of continuous subcutaneous insulin infusion in the treatment of diabetes and implications in the use of rapid-acting insulin analogues. Minerva Endocrinol. 2013;38:321-328.
4. Crenier L, Abou-Elias C, Corvilain B. Glucose variability assessed by low blood glucose index is predictive of hypoglycemic events in patients with type 1 diabetes switched to pump therapy. Diabetes Care. 2013;36:2148-2153.
5. Boyle ME, Seifert KM, Beer KA, et al. Insulin pump therapy in the perioperative period: a review of care after implementation of institutional guidelines. J Diabetes Sci Technol. 2012;6:1016-1021.
6. Boyle ME, Seifert KM, Beer KA, et al. Guidelines for application of continuous subcutaneous insulin infusion (insulin pump) therapy in the perioperative period. J Diabetes Sci Technol. 2012;6:184-190.
7. Umpierrez GE, Smiley D, Jacobs S, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 Surgery). Diabetes Care. 2011; 34:256-261.
8. Clement S, Braithwaite SS, Magee MF, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27:553-591.
9. Golden SH, Peart-Vigilance C, Kao WH, Brancati FL. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care. 1999;22:1408-1414.
10. Frisch A, Chandra P, Smiley D, et al. Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery. Diabetes Care. 2010;33: 1783-1788.
11. Noschese ML, DiNardo MM, Donihi AC, et al. Patient outcomes after implementation of a protocol for inpatient insulin pump therapy. Endocr Pract. 2009; 15:415-424.
12. Cook CB, Boyle ME, Cisar NS, et al. Use of continuous subcutaneous insulin infusion (insulin pump) therapy in the hospital setting: proposed guidelines and outcomes measures. Diabetes Educ. 2005;31:849-857.
13. White WA Jr, Montalvo H, Monday JM. Continuous subcutaneous insulin infusion during general anesthesia: a case report. AANA J. 2004;72:353-357.
14. Nassar AA, Boyle ME, Seifert KM, et al. Insulin pump therapy in patients with diabetes undergoing surgery. Endocr Pract. 2012;18:49-55.
15. Corney SM, Dukatz T, Rosenblatt S, et al. Comparison of insulin pump therapy (continuous subcutaneous insulin infusion) to alternative methods for perioperative glycemic management in patients with planned postoperative admissions. J Diabetes Sci Technol. 2012;6:1003-1015.
16. Korytkowski M, Dinardo M, Donihi AC, Bigi L, Devita M. Evolution of a diabetes inpatient safety committee. Endocr Pract. 2006;12 Suppl 3:91-99.
17. DiNardo M, Donihi AC, Forte P, Gieraltowski L, Korytkowski M. Standardized glycemic management and perioperative glycemic outcomes in patients with diabetes mellitus who undergo same-day surgery. Endocr Pract. 2011;17:404-411.
18. Diltoer M, Camu F. Glucose homeostasis and insulin secretion during isoflurane anesthesia in humans. Anesthesiology. 1988;68:880-886.
19. Bromage PR, Shibata HR, Willoughby HW. Influence of prolonged epidural blockade on blood sugar and cortisol responses to operations upon the upper part of the abdomen and the thorax. Surg Gynecol Obstet. 1971;132:1051-1056.
20. Romano E, Gullo A. Hypoglycaemic coma following epidural analgesia. Anaesthesia. 1980;35:1084-1086.
21. Akhtar S, Barash PG, Inzucchi SE. Scientific principles and clinical implications of perioperative glucose regulation and control. Anesth Analg. 2010;110:478-497.
22. Noordzij PG, Boersma E, Schreiner F, et al. Increased preoperative glucose levels are associated with perioperative mortality in patients undergoing noncardiac, nonvascular surgery. Eur J Endocrinol. 2007;156:137-142.
23. Eberhart LH, Graf J, Morin AM, et al. Randomised controlled trial of the effect of oral premedication with dexamethasone on hyperglycaemic response to abdominal hysterectomy. Eur J Anaesthesiol. 2011;28:195-201.
24. Hans P, Vanthuyne A, Dewandre PY, Brichant JF, Bonhomme V. Blood glucose concentration profile after 10 mg dexamethasone in non-diabetic and type 2 diabetic patients undergoing abdominal surgery. Br J Anaesth. 2006;97:164-170.
25. Abdelmalak B, Ibrahim M, Yared JP, Modic MB, Nasr C. Perioperative glycemic management in insulin pump patients undergoing noncardiac surgery. Curr Pharm Des. 2012;18:6204-6214.
26. Underwood P, Askari R, Hurwitz S, Chamarthi B, Garg R. Preoperative A1C and clinical outcomes in patients with diabetes undergoing major noncardiac surgical procedures. Diabetes Care. 2014;37:611-616.